chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient was reported to have received a first shot of Moderna Covid-19 vaccine, and I had administered a second dose of Pfizer Covid-19 vaccine. At this time, i am not aware of any adverse reaction
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Erythema, Pain in extremity, Skin burning sensation, Urticaria
Clinical narrative: On 1/12/2021 patient received dose one of Pfizer COVID vaccine, complained of prickling of upper extremities, and mid back, no breathing difficulties, 50mg IM diphenhydramine administered, symptoms resolved.  Patient was advised by her PCP to take oral diphenhydramine prior to her second dose which pt. reports she did (50mg PO Benadryl) on 2/3/21 at 230PM in advance of dose 2 appt. On 2/3/2021 3:10 PM Pfizer COVID vaccine dose 2 was administered.  At 3:50, pt reported the same prickling sensation as previous vaccine dose, moved from respite area to exam room, Health officer was consulted, decision was made to give IM Benadryl.  When NP returned to exam room, patient's symptoms had progressed to feeling itchy and hot, which then quickly progressed to c/o tingling lips and roof of mouth.  facial erythema and eyelid edema were noted, at 3:59PM epipen 0.3mg dose administered, EMS activated, vital signs monitored and stable, paramedics arrived at 4:07 and assumed care,  Pt was alert and oriented and speaking throughout, pt was transported to ED at 4:15PM.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Eyelid oedema, Feeling hot, Paraesthesia, Paraesthesia oral
Clinical narrative: On 1/12/2021 patient received dose one of Pfizer COVID vaccine, complained of prickling of upper extremities, and mid back, no breathing difficulties, 50mg IM diphenhydramine administered, symptoms resolved.  Patient was advised by her PCP to take oral diphenhydramine prior to her second dose which pt. reports she did (50mg PO Benadryl) on 2/3/21 at 230PM in advance of dose 2 appt. On 2/3/2021 3:10 PM Pfizer COVID vaccine dose 2 was administered.  At 3:50, pt reported the same prickling sensation as previous vaccine dose, moved from respite area to exam room, Health officer was consulted, decision was made to give IM Benadryl.  When NP returned to exam room, patient's symptoms had progressed to feeling itchy and hot, which then quickly progressed to c/o tingling lips and roof of mouth.  facial erythema and eyelid edema were noted, at 3:59PM epipen 0.3mg dose administered, EMS activated, vital signs monitored and stable, paramedics arrived at 4:07 and assumed care,  Pt was alert and oriented and speaking throughout, pt was transported to ED at 4:15PM.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: On 1/12/2021 patient received dose one of Pfizer COVID vaccine, complained of prickling of upper extremities, and mid back, no breathing difficulties, 50mg IM diphenhydramine administered, symptoms resolved.  Patient was advised by her PCP to take oral diphenhydramine prior to her second dose which pt. reports she did (50mg PO Benadryl) on 2/3/21 at 230PM in advance of dose 2 appt. On 2/3/2021 3:10 PM Pfizer COVID vaccine dose 2 was administered.  At 3:50, pt reported the same prickling sensation as previous vaccine dose, moved from respite area to exam room, Health officer was consulted, decision was made to give IM Benadryl.  When NP returned to exam room, patient's symptoms had progressed to feeling itchy and hot, which then quickly progressed to c/o tingling lips and roof of mouth.  facial erythema and eyelid edema were noted, at 3:59PM epipen 0.3mg dose administered, EMS activated, vital signs monitored and stable, paramedics arrived at 4:07 and assumed care,  Pt was alert and oriented and speaking throughout, pt was transported to ED at 4:15PM.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Liver function test, Rash, Rash papular, Rash pruritic
Clinical narrative: she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Right on12Jan2021 (Batch/Lot Number: EK9231) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient's medical history includes child asthma, since resolved.The patient previously took received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Right on 23Dec2020 (Batch/Lot Number: EK5730) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient was healthy and didn't take any medication. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.On 17Jan2021 5 days after vaccination,the patient experienced onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face.2 days ago, she was seen in urgent care and given prednisone and antihistamines (Triamcinolone cream, Benadryl, Tylenol and Atarax). patient has had no improvement, no mucosal involvement, no fevers or chills, no joint or body aches.  Patient had no new exposures and medications. Patient was the only one in the house with the symptoms.  Patient occupation was a nurse but had no known exposures. The outcomes of the all the events was recovering.  Follow-up attempts are completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis
Clinical narrative: she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Right on12Jan2021 (Batch/Lot Number: EK9231) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient's medical history includes child asthma, since resolved.The patient previously took received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Right on 23Dec2020 (Batch/Lot Number: EK5730) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient was healthy and didn't take any medication. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.On 17Jan2021 5 days after vaccination,the patient experienced onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face.2 days ago, she was seen in urgent care and given prednisone and antihistamines (Triamcinolone cream, Benadryl, Tylenol and Atarax). patient has had no improvement, no mucosal involvement, no fevers or chills, no joint or body aches.  Patient had no new exposures and medications. Patient was the only one in the house with the symptoms.  Patient occupation was a nurse but had no known exposures. The outcomes of the all the events was recovering.  Follow-up attempts are completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash maculo-papular, Rash pruritic
Clinical narrative: she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; she had onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Right on12Jan2021 (Batch/Lot Number: EK9231) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient's medical history includes child asthma, since resolved.The patient previously took received bnt162b2 (PFIZER-BIONTECH COIVD-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Right on 23Dec2020 (Batch/Lot Number: EK5730) as SINGLE DOSE for covid-19 immunisation (age at vaccination was 35years). Patient was healthy and didn't take any medication. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.On 17Jan2021 5 days after vaccination,the patient experienced onset of a diffuse pruritic macular papular rash on arms, chest and back and mildly on her face.2 days ago, she was seen in urgent care and given prednisone and antihistamines (Triamcinolone cream, Benadryl, Tylenol and Atarax). patient has had no improvement, no mucosal involvement, no fevers or chills, no joint or body aches.  Patient had no new exposures and medications. Patient was the only one in the house with the symptoms.  Patient occupation was a nurse but had no known exposures. The outcomes of the all the events was recovering.  Follow-up attempts are completed and no further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pruritus, Injection site reaction, Rash erythematous
Clinical narrative: red rash at the site; vaccination site was itchy; This is a spontaneous report from a contactable consumer (patient, reported for herself). A 71-year-old female patient (who was not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9262, expiry date: unknown) dose 1 via an unspecified route of administration, in left arm on 26Jan2021 09:15 AM(at the age of 71-years-old), as a single for Covid-19 immunization at Health Clinic/ Administration facility. The patient medical history was not reported, and the patient had known allergies: amoxicillin. The patient received concomitant medications in two weeks of vaccination. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 03Feb2021, day 9 following the first dose of vaccine, the patient experienced that the vaccination site was itchy. The following day there was a red rash at the site. The rash was circular and about four inches long and two inches wide. It was not a raised rash. Patient did not receive treatment for the events. The outcome of the events was not recovered.   No further information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: red rash at the site; vaccination site was itchy; This is a spontaneous report from a contactable consumer (patient, reported for herself). A 71-year-old female patient (who was not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9262, expiry date: unknown) dose 1 via an unspecified route of administration, in left arm on 26Jan2021 09:15 AM(at the age of 71-years-old), as a single for Covid-19 immunization at Health Clinic/ Administration facility. The patient medical history was not reported, and the patient had known allergies: amoxicillin. The patient received concomitant medications in two weeks of vaccination. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 03Feb2021, day 9 following the first dose of vaccine, the patient experienced that the vaccination site was itchy. The following day there was a red rash at the site. The rash was circular and about four inches long and two inches wide. It was not a raised rash. Patient did not receive treatment for the events. The outcome of the events was not recovered.   No further information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain
Clinical narrative: Upper Abdominal pain under middle to left rib cage; This is a spontaneous report from a contactable consumer (reported for herself).  A 49-years-old adult non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809) administered in left arm via an unknown route of administration, on 13Feb2021 at 11:45 as SINGLE DOSE for covid-19 immunization. Medical history included autoimmune disorder, stroke. Concomitant medications within 2 weeks of vaccination included Hydroxychloroquine Sulfate (PLAQUENIL), Fish oil, Zingiber officinale (GINGER), Curcuma longa (TURMERIC) and Multivitamins. On 13Feb2021 at 12:15, the patient experienced upper abdominal pain under middle to left rib cage. The outcome of the event was not recovered.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Upper Abdominal pain under middle to left rib cage; This is a spontaneous report from a contactable consumer (reported for herself).  A 49-years-old adult non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809) administered in left arm via an unknown route of administration, on 13Feb2021 at 11:45 as SINGLE DOSE for covid-19 immunization. Medical history included autoimmune disorder, stroke. Concomitant medications within 2 weeks of vaccination included Hydroxychloroquine Sulfate (PLAQUENIL), Fish oil, Zingiber officinale (GINGER), Curcuma longa (TURMERIC) and Multivitamins. On 13Feb2021 at 12:15, the patient experienced upper abdominal pain under middle to left rib cage. The outcome of the event was not recovered.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Nervousness, Palpitations
Clinical narrative: Upper Abdominal pain under middle to left rib cage; This is a spontaneous report from a contactable consumer (reported for herself).  A 49-years-old adult non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809) administered in left arm via an unknown route of administration, on 13Feb2021 at 11:45 as SINGLE DOSE for covid-19 immunization. Medical history included autoimmune disorder, stroke. Concomitant medications within 2 weeks of vaccination included Hydroxychloroquine Sulfate (PLAQUENIL), Fish oil, Zingiber officinale (GINGER), Curcuma longa (TURMERIC) and Multivitamins. On 13Feb2021 at 12:15, the patient experienced upper abdominal pain under middle to left rib cage. The outcome of the event was not recovered.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: headache; Exhausted; Chills; Joint Pain; achy pain; Flu; Eye floaters; Feeling Strange; Nauseaus; Dizzy; This is a spontaneous report was received from a contactable consumer or other non hcp. A 77-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Feb2021 14:00 (at the age of 77-year-old) as single dose for COVID-19 immunization. The patient's medical history included digestion problems, ongoing coeliac disease and allergy to gluten. Concomitant medications included vitamin b complex (vitamin b), zinc (zinc), vitamin c [ascorbic acid] (vitamin c [ascorbic acid]), colecalciferol (vitamin d [colecalciferol]), bifidobacterium lactis (Probiotic [bifidobacterium lactis]). The patient was not pregnant at the time of vaccination. The patient had not received other vaccine in four weeks. On 05Feb2021 at 18:00, the patient was exhausted and experienced chills, headache, joint pain started in left ankle, later she had achy pains all over and felt lousy like she had the flu. The patient had new floaters in her eyes and a strange feeling in her head and was also extremely nauseous and dizzy. The patient did not take any treatment. The patient was not tested for covid prior vaccination and post vaccination. The outcome of the events was recovered on an unspecified date in 2021. Follow up attempts are completed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Headache, Influenza like illness, Nausea, Vitreous floaters
Clinical narrative: headache; Exhausted; Chills; Joint Pain; achy pain; Flu; Eye floaters; Feeling Strange; Nauseaus; Dizzy; This is a spontaneous report was received from a contactable consumer or other non hcp. A 77-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Feb2021 14:00 (at the age of 77-year-old) as single dose for COVID-19 immunization. The patient's medical history included digestion problems, ongoing coeliac disease and allergy to gluten. Concomitant medications included vitamin b complex (vitamin b), zinc (zinc), vitamin c [ascorbic acid] (vitamin c [ascorbic acid]), colecalciferol (vitamin d [colecalciferol]), bifidobacterium lactis (Probiotic [bifidobacterium lactis]). The patient was not pregnant at the time of vaccination. The patient had not received other vaccine in four weeks. On 05Feb2021 at 18:00, the patient was exhausted and experienced chills, headache, joint pain started in left ankle, later she had achy pains all over and felt lousy like she had the flu. The patient had new floaters in her eyes and a strange feeling in her head and was also extremely nauseous and dizzy. The patient did not take any treatment. The patient was not tested for covid prior vaccination and post vaccination. The outcome of the events was recovered on an unspecified date in 2021. Follow up attempts are completed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Headache, Influenza, Nausea, Pain
Clinical narrative: headache; Exhausted; Chills; Joint Pain; achy pain; Flu; Eye floaters; Feeling Strange; Nauseaus; Dizzy; This is a spontaneous report was received from a contactable consumer or other non hcp. A 77-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Feb2021 14:00 (at the age of 77-year-old) as single dose for COVID-19 immunization. The patient's medical history included digestion problems, ongoing coeliac disease and allergy to gluten. Concomitant medications included vitamin b complex (vitamin b), zinc (zinc), vitamin c [ascorbic acid] (vitamin c [ascorbic acid]), colecalciferol (vitamin d [colecalciferol]), bifidobacterium lactis (Probiotic [bifidobacterium lactis]). The patient was not pregnant at the time of vaccination. The patient had not received other vaccine in four weeks. On 05Feb2021 at 18:00, the patient was exhausted and experienced chills, headache, joint pain started in left ankle, later she had achy pains all over and felt lousy like she had the flu. The patient had new floaters in her eyes and a strange feeling in her head and was also extremely nauseous and dizzy. The patient did not take any treatment. The patient was not tested for covid prior vaccination and post vaccination. The outcome of the events was recovered on an unspecified date in 2021. Follow up attempts are completed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Vitreous floaters
Clinical narrative: headache; Exhausted; Chills; Joint Pain; achy pain; Flu; Eye floaters; Feeling Strange; Nauseaus; Dizzy; This is a spontaneous report was received from a contactable consumer or other non hcp. A 77-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Feb2021 14:00 (at the age of 77-year-old) as single dose for COVID-19 immunization. The patient's medical history included digestion problems, ongoing coeliac disease and allergy to gluten. Concomitant medications included vitamin b complex (vitamin b), zinc (zinc), vitamin c [ascorbic acid] (vitamin c [ascorbic acid]), colecalciferol (vitamin d [colecalciferol]), bifidobacterium lactis (Probiotic [bifidobacterium lactis]). The patient was not pregnant at the time of vaccination. The patient had not received other vaccine in four weeks. On 05Feb2021 at 18:00, the patient was exhausted and experienced chills, headache, joint pain started in left ankle, later she had achy pains all over and felt lousy like she had the flu. The patient had new floaters in her eyes and a strange feeling in her head and was also extremely nauseous and dizzy. The patient did not take any treatment. The patient was not tested for covid prior vaccination and post vaccination. The outcome of the events was recovered on an unspecified date in 2021. Follow up attempts are completed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Influenza like illness, Nausea, Pain, Sensory disturbance
Clinical narrative: headache; Exhausted; Chills; Joint Pain; achy pain; Flu; Eye floaters; Feeling Strange; Nauseaus; Dizzy; This is a spontaneous report was received from a contactable consumer or other non hcp. A 77-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Feb2021 14:00 (at the age of 77-year-old) as single dose for COVID-19 immunization. The patient's medical history included digestion problems, ongoing coeliac disease and allergy to gluten. Concomitant medications included vitamin b complex (vitamin b), zinc (zinc), vitamin c [ascorbic acid] (vitamin c [ascorbic acid]), colecalciferol (vitamin d [colecalciferol]), bifidobacterium lactis (Probiotic [bifidobacterium lactis]). The patient was not pregnant at the time of vaccination. The patient had not received other vaccine in four weeks. On 05Feb2021 at 18:00, the patient was exhausted and experienced chills, headache, joint pain started in left ankle, later she had achy pains all over and felt lousy like she had the flu. The patient had new floaters in her eyes and a strange feeling in her head and was also extremely nauseous and dizzy. The patient did not take any treatment. The patient was not tested for covid prior vaccination and post vaccination. The outcome of the events was recovered on an unspecified date in 2021. Follow up attempts are completed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial pain, Headache, Herpes zoster
Clinical narrative: Got a case of SHINGLES which started pain in face and jaw Feb24; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right arm on 05Feb2021 20:45 (Lot Number: 3302) as single for COVID-19 immunization. Medical history included intermittent high blood pressure and shellfish allergy; from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient got a case of shingles; had symptoms started as pain in face and jaw on 24Feb2021 with outcome of not recovered. The event was assessed as non-serious. Think related possibly to getting vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not received any other medications within 2 weeks of vaccination. Event resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event were prednisone and Valtrex. He started Valtrex on 02Mar2021 and will take it through 12Mar2021. For the prednisone he has two days left. He started it on 02Mar2021 and it is a five day course. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Got a case of SHINGLES which started pain in face and jaw Feb24; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right arm on 05Feb2021 20:45 (Lot Number: 3302) as single for COVID-19 immunization. Medical history included intermittent high blood pressure and shellfish allergy; from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient got a case of shingles; had symptoms started as pain in face and jaw on 24Feb2021 with outcome of not recovered. The event was assessed as non-serious. Think related possibly to getting vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not received any other medications within 2 weeks of vaccination. Event resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event were prednisone and Valtrex. He started Valtrex on 02Mar2021 and will take it through 12Mar2021. For the prednisone he has two days left. He started it on 02Mar2021 and it is a five day course. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Oropharyngeal pain, Pharyngeal swelling, Swollen tongue
Clinical narrative: 1/2 hr after receiving dose my throat and tongue swelled up; 1/2 hr after receiving dose my throat and tongue swelled up; My chest started bothering me and I was short of brreathe.; Sore throat; This is a spontaneous report from a contactable consumer (patient). A 76-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported) via an unspecified route of administration, in right arm on 08Mar2021 10:30 as first dose single for covid-19 immunisation. Medical history included known allergies to various chemicals, foods, red dyes, high blood pressure and AFIB. Concomitant medications included hydrochlorothiazide, lisinopril, apixaban (ELIQUIS), montelukast, duloxetine and metoprolol tartrate all are taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient reports a half hour after she left the facility, she started getting a sore throat, then her throat and tongue swelled up. A little later my chest started bothering me and patient was short of breath on 08Mar2021 11:00 AM. Patient states she is getting better very slowly. This lasted all night and started to ease up the next day. patient took some Benadryl and that helped. As per the reporter seriousness criteria reported as medically significant. Patient received treatment that patient took of Benadryl and she has an inhaler. The outcome of the events was recovering.  Follow up needed and additional information has been requested.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Computerised tomogram thorax, Dyspnoea, Headache, Magnetic resonance imaging
Clinical narrative: 3 days after vaccine given, developed DOE/DOB. Worsened, so 4/13/21, went to ER. Diagnosis with Pulmonary Embolism (right Main Pulmonary Art.) Had MRI of brain with venogram-normal.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: 3 days after vaccine given, developed DOE/DOB. Worsened, so 4/13/21, went to ER. Diagnosis with Pulmonary Embolism (right Main Pulmonary Art.) Had MRI of brain with venogram-normal.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Dyspnoea, Dyspnoea exertional, Magnetic resonance imaging head normal, Pulmonary embolism
Clinical narrative: 3 days after vaccine given, developed DOE/DOB. Worsened, so 4/13/21, went to ER. Diagnosis with Pulmonary Embolism (right Main Pulmonary Art.) Had MRI of brain with venogram-normal.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Venogram normal
Clinical narrative: 3 days after vaccine given, developed DOE/DOB. Worsened, so 4/13/21, went to ER. Diagnosis with Pulmonary Embolism (right Main Pulmonary Art.) Had MRI of brain with venogram-normal.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Hemiparesis, Vertigo
Clinical narrative: STROKE; PASSED OUT; DIZZINESS; DID NOT FEEL WELL; HEARTBURN; HEADACHE ON THE FRONT LEFT SIDE; RECURRENT SEIZURE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, unknown, batch number: 1805029, expiry: UNKNOWN) dose was not reported once a total on left deltoid, administered on 28-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021 patient went to the hospital because patient did not feel well and was given seasick pills. Two days later patient was still not feeling well and went to hospital, where the doctor said that patient having a Stroke, and patient in the middle of a Stroke. The doctor administered intravenous to patient .The patient was hospitalized for 3-4 days then transferred to Hospital (where patient is insured) and was hospitalized for 4-5 day. On an unspecified date in 2021, the patient had recurrent Seizure .Three days in a row and then one day rest and then it came back again, basically for the month  came different times. Patient said his eyes would roll back to his head. On unspecified date in 2021, patient had dizziness and passed out and went to hospital  where they said they should have never released patient. Patient was hospitalized for 2 days and did work up. Then hospital took patient back and they didn't do what hospital did. Patient mentioned feeling better at hospital with the treatment they provided him but when  hospital cared for patient, they did not use the same. Patient  also mentioned that he was sent to rehab to learn how to walk. Patient had experienced heartburns  but they did not give him medication for heartburn. Patient was upset and got his friend to buy Antacid for him and he took it with relief. Patient used a walker/cane to get around and was perfectly fine before. On unspecified date in 2021 patient experienced headache on the front left side of the head (like someone is stepping). The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The outcome of the headache on the front left side, dizziness, recurrent seizure, heartburn, stroke, passed out and did not feel well was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210507602-COVID-19 VACCINE AD26.COV2.S-stroke, recurrent seizure, passed out, dizziness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210507602-COVID-19 VACCINE AD26.COV2.S-did not feel well. This event(s) is labeled per RSI and is therefore considered potentially related.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Dizziness, Dyspepsia, Headache, Loss of consciousness
Clinical narrative: STROKE; PASSED OUT; DIZZINESS; DID NOT FEEL WELL; HEARTBURN; HEADACHE ON THE FRONT LEFT SIDE; RECURRENT SEIZURE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, unknown, batch number: 1805029, expiry: UNKNOWN) dose was not reported once a total on left deltoid, administered on 28-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021 patient went to the hospital because patient did not feel well and was given seasick pills. Two days later patient was still not feeling well and went to hospital, where the doctor said that patient having a Stroke, and patient in the middle of a Stroke. The doctor administered intravenous to patient .The patient was hospitalized for 3-4 days then transferred to Hospital (where patient is insured) and was hospitalized for 4-5 day. On an unspecified date in 2021, the patient had recurrent Seizure .Three days in a row and then one day rest and then it came back again, basically for the month  came different times. Patient said his eyes would roll back to his head. On unspecified date in 2021, patient had dizziness and passed out and went to hospital  where they said they should have never released patient. Patient was hospitalized for 2 days and did work up. Then hospital took patient back and they didn't do what hospital did. Patient mentioned feeling better at hospital with the treatment they provided him but when  hospital cared for patient, they did not use the same. Patient  also mentioned that he was sent to rehab to learn how to walk. Patient had experienced heartburns  but they did not give him medication for heartburn. Patient was upset and got his friend to buy Antacid for him and he took it with relief. Patient used a walker/cane to get around and was perfectly fine before. On unspecified date in 2021 patient experienced headache on the front left side of the head (like someone is stepping). The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The outcome of the headache on the front left side, dizziness, recurrent seizure, heartburn, stroke, passed out and did not feel well was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210507602-COVID-19 VACCINE AD26.COV2.S-stroke, recurrent seizure, passed out, dizziness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210507602-COVID-19 VACCINE AD26.COV2.S-did not feel well. This event(s) is labeled per RSI and is therefore considered potentially related.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Seizure
Clinical narrative: STROKE; PASSED OUT; DIZZINESS; DID NOT FEEL WELL; HEARTBURN; HEADACHE ON THE FRONT LEFT SIDE; RECURRENT SEIZURE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, unknown, batch number: 1805029, expiry: UNKNOWN) dose was not reported once a total on left deltoid, administered on 28-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021 patient went to the hospital because patient did not feel well and was given seasick pills. Two days later patient was still not feeling well and went to hospital, where the doctor said that patient having a Stroke, and patient in the middle of a Stroke. The doctor administered intravenous to patient .The patient was hospitalized for 3-4 days then transferred to Hospital (where patient is insured) and was hospitalized for 4-5 day. On an unspecified date in 2021, the patient had recurrent Seizure .Three days in a row and then one day rest and then it came back again, basically for the month  came different times. Patient said his eyes would roll back to his head. On unspecified date in 2021, patient had dizziness and passed out and went to hospital  where they said they should have never released patient. Patient was hospitalized for 2 days and did work up. Then hospital took patient back and they didn't do what hospital did. Patient mentioned feeling better at hospital with the treatment they provided him but when  hospital cared for patient, they did not use the same. Patient  also mentioned that he was sent to rehab to learn how to walk. Patient had experienced heartburns  but they did not give him medication for heartburn. Patient was upset and got his friend to buy Antacid for him and he took it with relief. Patient used a walker/cane to get around and was perfectly fine before. On unspecified date in 2021 patient experienced headache on the front left side of the head (like someone is stepping). The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The outcome of the headache on the front left side, dizziness, recurrent seizure, heartburn, stroke, passed out and did not feel well was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210507602-COVID-19 VACCINE AD26.COV2.S-stroke, recurrent seizure, passed out, dizziness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210507602-COVID-19 VACCINE AD26.COV2.S-did not feel well. This event(s) is labeled per RSI and is therefore considered potentially related.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Hypokalaemia, Occult blood positive, Syncope
Clinical narrative: AKI (acute kidney injury)
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury
Clinical narrative: AKI (acute kidney injury)
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, Back pain, Cardioversion, Dyspnoea, Echocardiogram
Clinical narrative: host of issues that culminated into atrial fibrillation and heart inflammation; host of issues that culminated into atrial fibrillation and heart inflammation; This is a spontaneous report from a contactable consumer, the patient, based on information received by Pfizer from BioNTech SE (manufacturer control number 46869). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, second dose) solution for injection intramuscular on an unknown date (at the age of 37-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on an unknown date. After having the second Pfizer vaccine, the patient had a host of issues that culminated into atrial fibrillation and heart inflammation. The outcome of the events atrial fibrillation and heart inflammation was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Hyperhidrosis
Clinical narrative: host of issues that culminated into atrial fibrillation and heart inflammation; host of issues that culminated into atrial fibrillation and heart inflammation; This is a spontaneous report from a contactable consumer, the patient, based on information received by Pfizer from BioNTech SE (manufacturer control number 46869). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, second dose) solution for injection intramuscular on an unknown date (at the age of 37-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on an unknown date. After having the second Pfizer vaccine, the patient had a host of issues that culminated into atrial fibrillation and heart inflammation. The outcome of the events atrial fibrillation and heart inflammation was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, Myocarditis
Clinical narrative: host of issues that culminated into atrial fibrillation and heart inflammation; host of issues that culminated into atrial fibrillation and heart inflammation; This is a spontaneous report from a contactable consumer, the patient, based on information received by Pfizer from BioNTech SE (manufacturer control number 46869). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, second dose) solution for injection intramuscular on an unknown date (at the age of 37-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on an unknown date. After having the second Pfizer vaccine, the patient had a host of issues that culminated into atrial fibrillation and heart inflammation. The outcome of the events atrial fibrillation and heart inflammation was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acoustic stimulation tests, Deafness, Magnetic resonance imaging
Clinical narrative: I lost my hearing in my right ear
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acoustic stimulation tests, Deafness
Clinical narrative: I lost my hearing in my right ear
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Muscle twitching
Clinical narrative: Muscle twitches; The initial case was missing the following minimum criteria: no Identifiable reporter. Upon receipt of follow-up information on 19Apr2021 this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer sponsored program Corporate (Pfizer) Social Media Platforms reported from a contactable consumer (patient). A 51-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8734), via an unspecified route of administration in left arm on 02Apr2021 at 11:00 (at the age of 51-years-old) at single dose for COVID-19 immunization. Medical history included ongoing morphea for about five years. There were no family history and concomitant medications. In Apr2021 (either the 02Apr2021 or 03Apr 2021), within 24 hours of getting the Pfizer COVID-19 vaccine, the patient had been experiencing muscle twitches for about 16 or 17 days (at the time of report). The patient asked whether she should get the second dose. The patient did not undergo lab tests and procedures. No treatment was received for the event. The outcome of the event was reported as worsened (not recovered).  No follow-up attempts are possible; No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching
Clinical narrative: Muscle twitches; The initial case was missing the following minimum criteria: no Identifiable reporter. Upon receipt of follow-up information on 19Apr2021 this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer sponsored program Corporate (Pfizer) Social Media Platforms reported from a contactable consumer (patient). A 51-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8734), via an unspecified route of administration in left arm on 02Apr2021 at 11:00 (at the age of 51-years-old) at single dose for COVID-19 immunization. Medical history included ongoing morphea for about five years. There were no family history and concomitant medications. In Apr2021 (either the 02Apr2021 or 03Apr 2021), within 24 hours of getting the Pfizer COVID-19 vaccine, the patient had been experiencing muscle twitches for about 16 or 17 days (at the time of report). The patient asked whether she should get the second dose. The patient did not undergo lab tests and procedures. No treatment was received for the event. The outcome of the event was reported as worsened (not recovered).  No follow-up attempts are possible; No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Computerised tomogram normal, Cyanosis, Disturbance in attention, Dyspnoea
Clinical narrative: Had difficulty seeing clearly.  All the colors on the packages in the grocery store shelf were running together.  This occurred for about three minutes, then completely locked up.  Fell backwards and began having a seizure.  No history of seizures prior to this.  Difficulty breathing, completely locked up.  Appears to be a tonic clonic seizure.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Exophthalmos, Fall, Joint dislocation, Loss of bladder sensation, Loss of consciousness
Clinical narrative: Had difficulty seeing clearly.  All the colors on the packages in the grocery store shelf were running together.  This occurred for about three minutes, then completely locked up.  Fell backwards and began having a seizure.  No history of seizures prior to this.  Difficulty breathing, completely locked up.  Appears to be a tonic clonic seizure.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure
Clinical narrative: Had difficulty seeing clearly.  All the colors on the packages in the grocery store shelf were running together.  This occurred for about three minutes, then completely locked up.  Fell backwards and began having a seizure.  No history of seizures prior to this.  Difficulty breathing, completely locked up.  Appears to be a tonic clonic seizure.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Dyspnoea, Electroencephalogram, Magnetic resonance imaging
Clinical narrative: Had difficulty seeing clearly.  All the colors on the packages in the grocery store shelf were running together.  This occurred for about three minutes, then completely locked up.  Fell backwards and began having a seizure.  No history of seizures prior to this.  Difficulty breathing, completely locked up.  Appears to be a tonic clonic seizure.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure, Tonic convulsion, Vision blurred
Clinical narrative: Had difficulty seeing clearly.  All the colors on the packages in the grocery store shelf were running together.  This occurred for about three minutes, then completely locked up.  Fell backwards and began having a seizure.  No history of seizures prior to this.  Difficulty breathing, completely locked up.  Appears to be a tonic clonic seizure.